Metrics as of 10/14/2026, 06:59 AM (Berlin time), refresh in progress.
Advanced Medical Solutions Group plc
Advanced Medical Solutions Group plc (AMS), along with its subsidiaries, specializes in the innovation, production, and worldwide distribution of advanced medical solutions. Its primary markets include wound treatment, surgical procedures, and wound closure, with a significant presence across the United Kingdom,…
1D
+0.0%
1W
-0.2%
1M
+0.4%
6M
+30.0%
YTD
+29.4%
1Y
+23.1%
2Y
+38.2%
5Y
-13.0%
10Y
+21.7%
Next earnings date
17/03/2027 (in 151 days)
Volatility around earnings
~29% stronger price swings than usual
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Register for free
Unlock all 11 scores
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 29/09/2026.
Robust business model that benefits noticeably from at least one megatrend.
Advanced Medical Solutions Group plc is a specialized healthcare manufacturer focused on developing and globally distributing medical solutions for surgical procedures and wound care. The company offers a broad range of products, including tissue adhesives such as LiquiBand, surgical suture materials, and collagen products under the RESORBA brand, as well as various wound management technologies such as alginates, hydrogels, and antimicrobial dressings under the ActivHeal brand. Operations are divided into Surgical and Woundcare segments and serve international markets, with a focus on Europe and the United States.
P/E
165.89
P/B
2.41
EV/EBITDA
14.12
RETURN ON EQUITY
-0.0%
NET MARGIN
-0.1%
DEBT/EQUITY
0.34
DIVIDEND YIELD
1.7%
AS OF
30/06/2026
FREE FLOAT
87.4%
FLOAT SHARES
189,192,664
AVG. DAILY VOLUME (30D)
1,122,017
Advanced Medical Solutions Group plc is a company in the Healthcare sector, Medical - Instruments & Supplies industry, headquartered in United Kingdom.
The CEO is Andrew Christopher Meredith, the company employs around 1,800 people.
The IPO was on 16/12/1994; the stock trades on LSE under the ticker AMS.L.
The next earnings date is 17/03/2027.
Around past earnings, price swings were roughly 29% stronger than usual.
Yes. The last dividend was £2.01 per share, ex-date 28/05/2026, paid on 26/06/2026.
The dividend yield is 1.7% (as of 30/06/2026).
Comparable stocks include ConvaTec Group, Intuitive Surgical, Becton, Dickinson and Company, ResMed, West Pharmaceutical Services, Sartorius, Solventum and Baxter International.
Clicking "Analyze stock" lets five strategies assess Advanced Medical Solutions Group against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.